MedTrace Logo

A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour

NCT06383871 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 233

Last updated 2026-01-21

No results posted yet for this study

Summary

This study is a multicentre, open phase I clinical study of dose escalation, dose extension and efficacy extension of HRS-7058 in subjects with advanced malignant tumour. To evaluate the safety, tolerability, pharmacokinetics and efficacy of HRS-7058.

Conditions

  • Advanced Malignant Tumour

Interventions

DRUG

HRS-7058 capsule/ HRS-7058 tablet

HRS-7058 capsule/ HRS-7058 tablet

Sponsors & Collaborators

  • Shandong Suncadia Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-06
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06383871 on ClinicalTrials.gov